Insulin-free Cow Milk Formula in Prevention of Type 1 Diabetes Associated Autoimmunity - FINDIA Pilot Study
Not Applicable
Completed
- Conditions
- Beta-cell Autoimmunity
- Registration Number
- NCT01055080
- Lead Sponsor
- Finnish Institute for Health and Welfare
- Brief Summary
The purpose of this study is to determine whether weaning to whey-based hydrolysed formula or essentially bovine insulin free whey-based FINDIA formula instead of standard cow's milk based formula is effective in the prevention of type 1 diabetes associated beta-cell autoimmunity in children at genetic risk of type 1 diabetes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 987
Inclusion Criteria
- HLA-conferred genetic susceptibility for type 1 diabetes
Exclusion Criteria
- Pre-term, maternal diabetes with insulin treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Beta-cell autoantibodies 3,6,12,24,36,48,60,72 months
- Secondary Outcome Measures
Name Time Method